Sun Pharma, Aurobindo recall drugs from US market

Sun Pharmaceutical Industries and Aurobindo Pharma are recalling products from the US market due to manufacturing issues. Sun Pharma's subsidiary is recalling 69,707 cartons of Cequa, used to treat dry eyes, for being "Subpotent." Aurobindo Pharma is recalling 9,890 bottles of Rasagiline Tablets, used for Parkinson's disease, due to "Failed dissolution specifications." The Indian pharmaceutical industry is the third largest in the world, with a market size of around USD 50 billion. India exported pharmaceuticals worth Rs 1,75,040 crore in 2021-22.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fnaKr6z
via IFTTT